Internal Medicine, Rheumatology · Naples, FL
NPI
1366531535
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
5495 Bryson Dr Ste 423
Naples, FL, 34109
Phone (239) 430-5522
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
241,559 services
Medicare patients, 2024
249
Average age 78
Drug cost, 2024
$1.2M
1,462 prescriptions
Company payments, 2025
$571
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aleksandra Granath was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 223,600 times for 54 patients. In total Aleksandra Granath billed 241,559 services in 39 codes, and Medicare paid $1.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 223,600 | 54 | $3.62 | $809K |
| J0897 Injection, denosumab, 1 mg | Office | 4,740 | 50 | $20.54 | $97K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,677 | 39 | $0.10 | $168 |
| 96401 Chemotherapy Administration | Office | 1,119 | 54 | $58.57 | $66K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 525 | 218 | $13.00 | $6,825 |
| 99215 Office E&M - Established | Office | 449 | 195 | $138.01 | $62K |
| 99214 Office E&M - Established | Office | 210 | 122 | $101.35 | $21K |
| 96372 Injection Administration | Office | 110 | 53 | $11.76 | $1,293 |
| 96365 Intravenous Infusion, Hydration | Office | 76 | 14 | $51.30 | $3,899 |
| 99205 Office E&M - New | Office | 34 | 34 | $179.18 | $6,092 |
| 20610 Joint Injection | Office | 27 | 15 | $53.37 | $1,441 |
| 20611 Joint Injection | Office | 23 | 16 | $81.71 | $1,879 |
| 20604 Joint Injection | Office | 21 | 13 | $65.81 | $1,382 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 16 | 14 | $4.73 | $75.6 |
By year: 2022 $1.4M for 233,797 services; 2023 $1.3M for 230,884 services; 2024 $1.3M for 241,559 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 13 | $5.88 | $76.44 |
Medicare prescription drug claims, 2024
In 2024, the drug Aleksandra Granath prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 403 prescriptions and refills. In total Aleksandra Granath wrote 1,462 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 403 | 1,177 | 129 | $18K |
| Methotrexate Methotrexate Sodium | 221 | 606 | 70 | $7,369 |
| Prednisone Generic | 130 | 309 | 51 | $1,512 |
| Alendronate Sodium Generic | 104 | 290 | 35 | $1,285 |
| Gabapentin Generic | 89 | 239 | 29 | $1,362 |
| Folic Acid Generic | 81 | 225 | 23 | $1,483 |
| Cimzia (2 Pack) Certolizumab Pegol | 63 | 72 | Under 11 | $419K |
| Sulfasalazine Generic | 50 | 143 | 17 | $2,417 |
| Trazodone Hcl Generic | 31 | 93 | Under 11 | $171 |
| Hydrochlorothiazide Generic | 27 | 83 | Under 11 | $173 |
| Allopurinol Generic | 27 | 75 | Under 11 | $430 |
| Humira(Cf) Pen Adalimumab | 27 | 31 | Under 11 | $226K |
| Leflunomide Generic | 27 | 81 | Under 11 | $1,790 |
| Enbrel Sureclick Etanercept | 26 | 26 | Under 11 | $210K |
| Orencia Clickject Abatacept | 23 | 30 | Under 11 | $169K |
Brand drugs: 243 claims; generic drugs: 1,219 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aleksandra Granath $571 ($571 in general payments such as food, travel and fees) from 6 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $320.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.